Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 6 de 6
1.
J Infect Dis ; 224(6): 1024-1028, 2021 09 17.
Article En | MEDLINE | ID: mdl-33475730

Two transplant recipients (1 kidney and 1 hematopoietic stem cell) received maribavir (MBV) after cytomegalovirus (CMV) infection clinically resistant to standard therapy. Both patients achieved CMV DNA clearance within 30 and 18 days; however, the UL97 C480F variant emerged, causing recurrent CMV infection after a cumulative 2 months of MBV and 15 or 4 weeks of ganciclovir treatment, respectively. C480F was not detected under ganciclovir before MBV treatment. Recombinant phenotyping showed that C480F conferred the highest level of MBV resistance and ganciclovir cross-resistance, with impaired viral growth. Clinical follow-up and genotypic and phenotypic studies are essential for the assessment and optimization of patients with suspected MBV resistance.


Benzimidazoles/therapeutic use , Cytomegalovirus Infections/drug therapy , Cytomegalovirus/drug effects , Drug Resistance, Viral/genetics , Ganciclovir/therapeutic use , Hematopoietic Stem Cell Transplantation/adverse effects , Kidney Transplantation/adverse effects , Ribonucleosides/therapeutic use , Transplant Recipients , Adult , Antiviral Agents/pharmacology , Antiviral Agents/therapeutic use , Benzimidazoles/pharmacology , Cytomegalovirus/genetics , Drug Resistance, Viral/drug effects , Female , Ganciclovir/pharmacology , Hematopoietic Stem Cells , Humans , Mutation/drug effects , Organ Transplantation , Phosphotransferases (Alcohol Group Acceptor)/genetics , Phosphotransferases (Alcohol Group Acceptor)/therapeutic use , Ribonucleosides/pharmacology , Treatment Outcome
2.
Enferm Infecc Microbiol Clin ; 34 Suppl 3: 40-6, 2016 Jul.
Article Es | MEDLINE | ID: mdl-27474246

Lower respiratory tract infections remain one of the most common causes of mortality worldwide, which is why early diagnosis is crucial. Traditionally the microbiological diagnosis of these infections has been based on conventional methods including culture on artificial media for isolation of bacteria and fungi and cell cultures for virus and antibody or antigen detection using antigen-antibody reactions. The main drawback of the above mentioned methods is the time needed for an etiological diagnosis of the infection. The techniques based on molecular biology have drawn much attention in recent decades as tools for rapid diagnosis of infections. Some techniques are very expensive, especially those that can detect various microorganisms in the same reaction, therefore the question that arises is whether the cost of such testing is justified by the information obtained and by the clinical impact that its implementation will determine. In this article we make a review of the various techniques of molecular biology applied to the diagnosis of pneumonia and focus primarily on analysing the impact they may have on the management of patients with acute respiratory tract infections.


Molecular Diagnostic Techniques , Respiratory Tract Infections/diagnosis , Bacteria/genetics , Bacteria/isolation & purification , Fungi/genetics , Fungi/isolation & purification , Humans , Respiratory Tract Infections/microbiology , Viruses/genetics , Viruses/isolation & purification
3.
Enferm. infecc. microbiol. clín. (Ed. impr.) ; 34(supl.3): 40-46, jul. 2016.
Article Es | IBECS | ID: ibc-170853

Las infecciones respiratorias bajas siguen siendo una de las causas más frecuentes de mortalidad en todo el mundo, de ahí que el diagnóstico precoz sea fundamental. Tradicionalmente, el diagnóstico microbiológico de este tipo de infecciones se ha basado en métodos convencionales que incluyen cultivos en medios artificiales para aislamiento de bacterias y hongos y cultivos celulares para virus, así como en la detección antigénica o de anticuerpos mediante reacciones antígeno-anticuerpo. El principal inconveniente de las metodologías anteriormente citadas es el tiempo necesario para obtener un diagnóstico etiológico de la infección. Las técnicas basadas en la biología molecular han irrumpido con fuerza en las últimas décadas como herramientas de diagnóstico rápido de las infecciones. Algunas de estas técnicas -sobre todo aquellas que pueden detectar diversos microorganismos en la misma reacción- acostumbran a ser caras, por lo que la cuestión que se plantea es si el gasto de tales ensayos se ve justificado por la información obtenida y por el impacto clínico que su implementación determina. En este artículo se pretende hacer una revisión de las diversas técnicas de biología molecular aplicadas al diagnóstico de las infecciones respiratorias, centrándose fundamentalmente en la neumonía, y analizar el impacto que pueden tener en el manejo del paciente con infección respiratoria aguda


Lower respiratory tract infections remain one of the most common causes of mortality worldwide, which is why early diagnosis is crucial. Traditionally the microbiological diagnosis of these infections has been based on conventional methods including culture on artificial media for isolation of bacteria and fungi and cell cultures for virus and antibody or antigen detection using antigen-antibody reactions. The main drawback of the above mentioned methods is the time needed for an etiological diagnosis of the infection. The techniques based on molecular biology have drawn much attention in recent decades as tools for rapid diagnosis of infections. Some techniques are very expensive, especially those that can detect various microorganisms in the same reaction, therefore the question that arises is whether the cost of such testing is justified by the information obtained and by the clinical impact that its implementation will determine. In this article we make a review of the various techniques of molecular biology applied to the diagnosis of pneumonia and focus primarily on analysing the impact they may have on the management of patients with acute respiratory tract infections


Humans , Molecular Diagnostic Techniques , Respiratory Tract Infections/diagnosis , Bacteria/isolation & purification , Fungi/isolation & purification , Virus Diseases/genetics , Respiratory Tract Infections/microbiology
6.
Hepatogastroenterology ; 52(63): 800-7, 2005.
Article En | MEDLINE | ID: mdl-15966208

BACKGROUND/AIMS: There is some confusion as to the effectiveness of the available disinfectants for achieving "high level" disinfection, and the microbiologic method to assess the efficacy of the selected disinfectant regime. The "in use" method is adequate for control and for establishing comparisons between different disinfectants. METHODOLOGY: This study compares the efficacy of the different disinfectants and disinfection regimes available, including automatic systems to the 20-minute immersion in 20 degrees C 2%-alkaline-glutaraldehyde (AG). After cleaning and disinfection the effluent obtained from each channel was collected under sterile conditions. A total of 0.1 mL of the effluent was introduced in liquid thioglycolate, an additional 0.1 mL was seeded in solid blood agar and in MacConkey agar medium, and maintained for 48 hours at 37 degrees C. Thioglycolate media turbidity after a 48-hour culture indicates bacterial growth. RESULTS: The disinfectants used were 2% AG, 0.125% and 0.27% glutaraldehyde, glutaraldehydephenol-phenate, peracetic acid, N-duopropenida, 13%-H2O2-27%-lactic acid and ortho-phtalaldehyde using manual and automated methods. Most of the disinfectants available obtain similar or better results compared with 20' 2% AG. The best results (bacterial reduction greater than 3 log10), were those obtained using 20-minute 1/4 or 1/2 glutaraldehydephenol-phenate, 10-minute peracetic acid, or hydrogen-peroxide compounds, 5-minute 0.125% and 0.27% AG at high temperature and 5-minute 0.5% ortho-phtalaldehyde. CONCLUSIONS: A sensitive microbiologic method described may be useful in the control of disinfection and allowed: 1) knowledge of the limits of the efficacy of the disinfection methods usually used, 2) effective comparison of the different disinfectants and disinfection regimes and 3) awareness of the need for microbiologic regulations in assessing "high level" disinfection.


Disinfectants/pharmacology , Disinfection/methods , Endoscopes, Gastrointestinal/microbiology , Colony Count, Microbial , Dose-Response Relationship, Drug , Glutaral/pharmacology , Humans , Hydrogen-Ion Concentration
...